Clinical Value of 18 F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer

Abstract

In the present study, etPET/CT revealed metabolically active lesions in complete responders after EOC primary therapy, but they were insignificant for the patient's prognosis. The current study does not favour routine use of F-FDG PET/CT after EOC primary treatment for complete responders.

Ovarian Cancer

“…Diffusion-weighted imaging magnetic resonance imaging has generated a lot of interest and seems to show superiority in some hands, but 18 F-fluorodeoxyglucose positron emission tomography (FDG PET) is also considered by others to be a valuable tool in the management of serous ovarian carcinoma. The review by Hynninen et al [7] will inform the reader about the value of FDG PET/ computed tomography. Finally, the molecular pathology is now very much the standard of care and the excellent review by Cojocaru and colleagues [8] describes the clinical consequences of the different molecular subtypes in high grade epithelial ovarian carcinoma.…”